DuPont de Nemours, Inc. (NYSE:DD) Q3 2024 Earnings Preview

• Analysts expect earnings per share (EPS) of $1.03 and revenue of $3.2 billion, indicating growth from the previous year.
• The anticipated EPS reflects a 12% increase year-over-year, supported by positive analyst sentiment.
• DuPont's shares have risen by 24.4% over the past year, outperforming the industry average.

DuPont de Nemours, Inc. (NYSE:DD) is a prominent player in the chemicals industry, known for its innovation-driven approach and diverse product offerings. The company is set to release its third-quarter 2024 earnings on November 5. Analysts expect earnings per share (EPS) of $1.03 and revenue of $3.2 billion, reflecting growth from the previous year.

The anticipated EPS of $1.03 marks a 12% increase from the same quarter last year, as highlighted by Zacks Investment Research. This growth is supported by a 1.1% upward revision in the consensus EPS estimate over the past 30 days, indicating positive analyst sentiment. Such revisions often correlate with short-term stock price movements, suggesting potential investor interest.

DuPont's revenue is projected to grow by 4.6% year-over-year, reaching $3.2 billion. This growth is attributed to the company's strategic investments in innovation and productivity, despite facing demand challenges in certain segments. The company's shares have risen by 24.4% over the past year, outperforming the Zacks Chemicals Diversified industry's 8.4% increase.

DuPont has a history of surpassing earnings expectations, with an average earnings surprise of 11.9% over the past four quarters. In the most recent quarter, the company delivered a 14.1% earnings surprise. This track record, combined with its strong liquidity position, as indicated by a current ratio of 2.21, positions DuPont well for continued growth.

The company's financial metrics, such as a P/E ratio of 51.91 and a price-to-sales ratio of 2.80, reflect investor confidence in its earnings and sales potential. Additionally, DuPont's low debt-to-equity ratio of 0.31 and an enterprise value to operating cash flow ratio of 18.92 highlight its solid financial health and efficient cash flow management.